GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has received an order dated 31st December 2025 from the Assistant Commissioner of State Tax, Mumbai, Maharashtra, for financial year 2021-22. The total demand is Rs. 35,07,895, broken down as Rs. 18,16,196 in tax, Rs. 15,10,080 in interest, and Rs. 1,81,619 in penalty. The demand relates to GST credit mismatch issues between the company's GST returns and supplier-reported details. The company has stated there is no impact on its financial operations and that it is evaluating the order to take appropriate action.
The demand amount of ~Rs. 35 lakh is immaterial relative to GSK Pharma's overall size and should not materially affect financials or stock price. Shareholders should note the company is still evaluating whether to contest or pay, so the final outcome is pending.